Mineralys Therapeutics • MLYS
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Jon Congleton$611.5M
Market Cap • 15/04/20242019
(há 5 anos)
2023
(1 year ago)
NASDAQ
Listagem
Radnor
Sede • Pennsylvania12
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MLYSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.